Jenifer Michelle Brown, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperaldosteronism | 10 | 2024 | 244 | 3.170 |
Why?
|
Aldosterone | 12 | 2024 | 868 | 1.810 |
Why?
|
Renin-Angiotensin System | 5 | 2018 | 739 | 0.950 |
Why?
|
Ammonia | 2 | 2023 | 236 | 0.880 |
Why?
|
Parathyroid Hormone | 6 | 2022 | 1797 | 0.840 |
Why?
|
Hypertension | 9 | 2024 | 8595 | 0.830 |
Why?
|
Renin | 7 | 2024 | 636 | 0.790 |
Why?
|
Myocardial Ischemia | 3 | 2023 | 2161 | 0.570 |
Why?
|
Hyperparathyroidism, Primary | 2 | 2022 | 161 | 0.570 |
Why?
|
Angiotensin II | 4 | 2018 | 850 | 0.510 |
Why?
|
Atherosclerosis | 4 | 2022 | 3524 | 0.510 |
Why?
|
Renal Plasma Flow | 2 | 2017 | 27 | 0.500 |
Why?
|
Coronary Artery Disease | 6 | 2023 | 6661 | 0.450 |
Why?
|
Captopril | 1 | 2013 | 266 | 0.430 |
Why?
|
Myocardial Perfusion Imaging | 3 | 2022 | 572 | 0.390 |
Why?
|
Spironolactone | 1 | 2013 | 411 | 0.340 |
Why?
|
Heart Failure | 3 | 2022 | 11835 | 0.330 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 1521 | 0.300 |
Why?
|
Coronary Circulation | 6 | 2023 | 1578 | 0.290 |
Why?
|
Kidney | 4 | 2023 | 7072 | 0.290 |
Why?
|
Receptors, Mineralocorticoid | 2 | 2017 | 164 | 0.270 |
Why?
|
Potassium | 2 | 2020 | 1318 | 0.240 |
Why?
|
Osteoporosis | 1 | 2014 | 1600 | 0.240 |
Why?
|
Cardiovascular Diseases | 5 | 2020 | 15740 | 0.230 |
Why?
|
Atrial Fibrillation | 1 | 2022 | 5201 | 0.220 |
Why?
|
Amiloride | 1 | 2022 | 116 | 0.210 |
Why?
|
Systemic Vasculitis | 1 | 2023 | 36 | 0.210 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2022 | 329 | 0.190 |
Why?
|
Minerals | 2 | 2018 | 283 | 0.160 |
Why?
|
Perfusion | 1 | 2023 | 1376 | 0.160 |
Why?
|
Cross-Sectional Studies | 7 | 2020 | 25928 | 0.150 |
Why?
|
Anemia, Pernicious | 1 | 2018 | 15 | 0.150 |
Why?
|
Expert Testimony | 1 | 2020 | 361 | 0.150 |
Why?
|
Vitamin D | 4 | 2018 | 3293 | 0.150 |
Why?
|
Research Report | 1 | 2020 | 370 | 0.140 |
Why?
|
Calcium | 4 | 2022 | 5726 | 0.140 |
Why?
|
Foreign-Body Migration | 1 | 2018 | 218 | 0.140 |
Why?
|
Physical Examination | 1 | 2022 | 1244 | 0.140 |
Why?
|
Calcitriol | 1 | 2018 | 297 | 0.130 |
Why?
|
Fibrosis | 1 | 2023 | 2042 | 0.130 |
Why?
|
Heart Atria | 1 | 2022 | 1344 | 0.130 |
Why?
|
Sodium Chloride Symporter Inhibitors | 1 | 2016 | 78 | 0.130 |
Why?
|
Humans | 33 | 2024 | 760261 | 0.120 |
Why?
|
p-Aminohippuric Acid | 1 | 2014 | 36 | 0.120 |
Why?
|
Sodium, Dietary | 2 | 2017 | 425 | 0.120 |
Why?
|
Positron-Emission Tomography | 4 | 2023 | 6457 | 0.120 |
Why?
|
Ischemia | 1 | 2022 | 1893 | 0.110 |
Why?
|
Device Removal | 1 | 2018 | 634 | 0.110 |
Why?
|
Coronary Vessels | 2 | 2023 | 3112 | 0.110 |
Why?
|
Blood Pressure | 4 | 2017 | 8523 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2023 | 5201 | 0.100 |
Why?
|
Calcium Channel Blockers | 1 | 2016 | 694 | 0.100 |
Why?
|
Diet, Sodium-Restricted | 1 | 2014 | 291 | 0.100 |
Why?
|
Female | 19 | 2022 | 391011 | 0.100 |
Why?
|
Psoriasis | 1 | 2020 | 939 | 0.100 |
Why?
|
Parathyroid Glands | 1 | 2013 | 518 | 0.100 |
Why?
|
Stroke Volume | 2 | 2022 | 5513 | 0.090 |
Why?
|
Fibroblast Growth Factors | 1 | 2017 | 867 | 0.090 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 2011 | 168 | 0.090 |
Why?
|
Consensus | 1 | 2020 | 3106 | 0.090 |
Why?
|
Cardiomyopathies | 1 | 2022 | 1945 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 12281 | 0.090 |
Why?
|
Diuretics | 1 | 2013 | 612 | 0.090 |
Why?
|
Middle Aged | 13 | 2021 | 220175 | 0.090 |
Why?
|
Vasoconstrictor Agents | 1 | 2013 | 651 | 0.090 |
Why?
|
Pituitary Gland | 1 | 2013 | 637 | 0.090 |
Why?
|
Male | 16 | 2022 | 359413 | 0.080 |
Why?
|
Glomerular Filtration Rate | 2 | 2017 | 2178 | 0.080 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15273 | 0.080 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2020 | 2129 | 0.080 |
Why?
|
Cardiology | 1 | 2020 | 1723 | 0.080 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2021 | 2160 | 0.080 |
Why?
|
Linear Models | 2 | 2017 | 5876 | 0.070 |
Why?
|
Hemodynamics | 2 | 2018 | 4169 | 0.070 |
Why?
|
Adiposity | 1 | 2017 | 1851 | 0.070 |
Why?
|
Hormone Replacement Therapy | 1 | 2013 | 756 | 0.070 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2013 | 1153 | 0.070 |
Why?
|
Hypogonadism | 1 | 2013 | 800 | 0.070 |
Why?
|
Stents | 1 | 2018 | 3303 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2018 | 3811 | 0.070 |
Why?
|
Prevalence | 2 | 2020 | 15687 | 0.070 |
Why?
|
Recombination, Genetic | 1 | 2011 | 1526 | 0.070 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20048 | 0.060 |
Why?
|
Risk Factors | 5 | 2022 | 74269 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12156 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2017 | 58947 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2013 | 2063 | 0.060 |
Why?
|
Retrospective Studies | 6 | 2022 | 80301 | 0.060 |
Why?
|
Bone Density | 1 | 2016 | 3528 | 0.050 |
Why?
|
Cell Cycle | 1 | 2011 | 2937 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2011 | 3735 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15827 | 0.050 |
Why?
|
Magnetic Resonance Angiography | 2 | 2018 | 1430 | 0.050 |
Why?
|
Aged | 7 | 2021 | 168995 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10829 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14482 | 0.050 |
Why?
|
Committee Membership | 1 | 2020 | 17 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2022 | 11891 | 0.050 |
Why?
|
Cohort Studies | 2 | 2022 | 41317 | 0.040 |
Why?
|
Incidence | 1 | 2017 | 21378 | 0.040 |
Why?
|
Iliac Vein | 1 | 2018 | 70 | 0.040 |
Why?
|
Prognosis | 2 | 2021 | 29636 | 0.040 |
Why?
|
Syphilis Serodiagnosis | 1 | 2018 | 37 | 0.040 |
Why?
|
Methylmalonic Acid | 1 | 2018 | 49 | 0.040 |
Why?
|
Treponema pallidum | 1 | 2018 | 47 | 0.040 |
Why?
|
Microcirculation | 1 | 2023 | 1279 | 0.040 |
Why?
|
Age Factors | 1 | 2014 | 18415 | 0.040 |
Why?
|
Adult | 5 | 2020 | 219847 | 0.030 |
Why?
|
Sensation Disorders | 1 | 2018 | 160 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2021 | 977 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2018 | 553 | 0.030 |
Why?
|
United States | 2 | 2020 | 72363 | 0.030 |
Why?
|
Critical Pathways | 1 | 2018 | 475 | 0.030 |
Why?
|
Vitamin B 12 | 1 | 2018 | 522 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2018 | 916 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1109 | 0.030 |
Why?
|
Water-Electrolyte Balance | 1 | 2015 | 334 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2017 | 1490 | 0.030 |
Why?
|
Postural Balance | 1 | 2018 | 617 | 0.030 |
Why?
|
Blood Vessels | 1 | 2018 | 1112 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2023 | 4560 | 0.020 |
Why?
|
Metabolome | 1 | 2018 | 976 | 0.020 |
Why?
|
Chromosome Breakage | 1 | 2011 | 159 | 0.020 |
Why?
|
S Phase | 1 | 2011 | 422 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2022 | 20484 | 0.020 |
Why?
|
Vitamin D Deficiency | 1 | 2018 | 1381 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3870 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12532 | 0.020 |
Why?
|
Tamoxifen | 1 | 2011 | 963 | 0.020 |
Why?
|
Registries | 1 | 2022 | 8449 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2011 | 2056 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 3604 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2011 | 1146 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22041 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2202 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2017 | 2296 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12968 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16543 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 42034 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12959 | 0.010 |
Why?
|
Young Adult | 1 | 2022 | 58673 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16905 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23363 | 0.010 |
Why?
|
Brain | 1 | 2018 | 26912 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36247 | 0.010 |
Why?
|
Time Factors | 1 | 2011 | 40133 | 0.010 |
Why?
|
Mutation | 1 | 2013 | 29950 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2013 | 64947 | 0.000 |
Why?
|
Adolescent | 1 | 2013 | 87747 | 0.000 |
Why?
|
Animals | 1 | 2015 | 167940 | 0.000 |
Why?
|